Xeris Biopharma Holdings

NasdaqGS:XERS Stock Report

Mkt Cap: US$179.5m

Xeris Biopharma Holdings Management

How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Paul Edick (66 yo)





Mr. Paul R. Edick serves as the Chief Executive Officer of Xeris Biopharma Holdings, Inc. since May 2021 in connection with the Strongbridge acquisition and has been its Chairman since 2021. He served as P...

CEO Compensation Analysis

How has Paul Edick's remuneration changed compared to Xeris Biopharma Holdings's earnings?
DateTotal Comp.SalaryCompany Earnings
Sep 30 2022n/an/a


Jun 30 2022n/an/a


Mar 31 2022n/an/a


Dec 31 2021US$4mUS$664k


Sep 30 2021n/an/a


Jun 30 2021n/an/a


Mar 31 2021n/an/a


Dec 31 2020US$2mUS$627k


Sep 30 2020n/an/a


Jun 30 2020n/an/a


Mar 31 2020n/an/a


Dec 31 2019US$4mUS$598k


Sep 30 2019n/an/a


Jun 30 2019n/an/a


Mar 31 2019n/an/a


Dec 31 2018US$1mUS$535k


Sep 30 2018n/an/a


Jun 30 2018n/an/a


Mar 31 2018n/an/a


Dec 31 2017US$1mUS$490k


Compensation vs Market: Paul's total compensation ($USD3.76M) is above average for companies of similar size in the US market ($USD1.75M).

Compensation vs Earnings: Paul's compensation has increased whilst the company is unprofitable.

Leadership Team

Paul Edick
Chairman & CEO1.5yrsUS$3.76m0.52%
$ 932.4k
John Shannon
President & COO1.08yrsUS$1.73m0.46%
$ 817.0k
Beth Hecht
Chief Legal Officer & Corporate Secretary1.08yrsUS$1.42m0.32%
$ 576.6k
Steven Prestrelski
Co-Founder & Chief Scientific Officer1.08yrsno data0.37%
$ 657.5k
Steven Pieper
Chief Financial Officer1.08yrsno data0.040%
$ 71.9k
Allison Wey
Senior Vice President of Investor Relations & Corporate Communications4.33yrsno datano data
Kenneth Johnson
Senior VP of Global Development & Medical Affairs1.08yrsno data0.0051%
$ 9.1k
Kevin McCulloch
Chief Commercial Officerno datano datano data


Average Tenure


Average Age

Experienced Management: XERS's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.

Board Members

Paul Edick
Chairman & CEO1.83yrsUS$3.76m0.52%
$ 932.4k
John Brooks
Scientific Advisory Board Memberno datano datano data
Orville Kolterman
Member of Scientific Advisory Boardno datano datano data
Jeffrey Sherman
Independent Director1.08yrsUS$73.07k0.037%
$ 66.5k
John Schmid
Lead Independent Director1.08yrsUS$105.07k0.0042%
$ 7.5k
Garheng Kong
Independent Non-Executive Director1.08yrsUS$41.02k0.037%
$ 66.2k
W. Ward
Member of Scientific Advisory Boardno datano datano data
Marla Persky
Independent Director1.08yrsUS$79.07k0%
$ 0
Morey Haymond
Scientific Advisory Board Memberno datano datano data
John Johnson
Independent Non-Executive Director1.08yrsUS$40.06k0.35%
$ 631.4k
Barbar-Jean Bormann-Kennedy
Independent Director1.08yrsUS$79.07k0%
$ 0
Dawn Halkuff
Independent Director1.08yrsUS$73.07k0%
$ 0


Average Tenure


Average Age

Experienced Board: XERS's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.